To include your compound in the COVID-19 Resource Center, submit it here.

Synovir thalidomide: Began a Phase II trial

Celgene Corp. (CELG), Warren, N.J.
Product:

Read the full 67 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE